{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:54:01Z","timestamp":1792547641431,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7264317"],"award-info":[{"award-number":["7264317"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09301131"],"award-info":[{"award-number":["2019ZX09301131"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-017"],"award-info":[{"award-number":["2021-I2M-1-017"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370041"],"award-info":[{"award-number":["82370041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001236","name":"Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.12.065","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:51:34Z","timestamp":1767397894000},"page":"2063-2080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Allergen-specific immunotherapy with Der p 1\/2 mRNA vaccines relieves house-dust-mite-induced allergic airway inflammation in a mouse model"],"prefix":"10.1016","volume":"34","author":[{"given":"Junda","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-4259","authenticated-orcid":false,"given":"Jia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.065_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108115","article-title":"Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future","volume":"237","author":"Hesse","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.065_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4168\/aair.2022.14.6.604","article-title":"Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update","volume":"14","author":"Wang","year":"2022","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.12.065_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(19)31147-X","article-title":"Prevalence, risk factors, and management of asthma in China: a national cross-sectional study","volume":"394","author":"Huang","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.065_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00281-019-00770-3","article-title":"Resolution of allergic asthma","volume":"41","author":"Finotto","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12016-019-08751-y","article-title":"Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA","volume":"57","author":"Guan","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib8","first-page":"1628","article-title":"[Natural course from rhinitis to asthma in the patients with autumnal pollinosis: a clinical study of 1096 patients]","volume":"86","author":"Yin","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ymthe.2025.12.065_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13223-018-0282-5","article-title":"Allergen-specific immunotherapy","volume":"14","author":"Moote","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ebiom.2019.11.006","article-title":"Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response","volume":"50","author":"Eckl-Dorna","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2025.12.065_bib11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/ACI.0000000000000585","article-title":"Duration of allergen immunotherapy for inhalant allergy","volume":"19","author":"Penagos","year":"2019","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11882-018-0790-x","article-title":"Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches","volume":"18","author":"Curin","year":"2018","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.ymthe.2025.12.065_bib13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jaip.2018.08.032","article-title":"Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?","volume":"6","author":"Valenta","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.ymthe.2025.12.065_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/all.13260","article-title":"House dust mites as potential carriers for IgE sensitization to bacterial antigens","volume":"73","author":"Dzoro","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.14300","article-title":"Past, present, and future of allergen immunotherapy vaccines","volume":"76","author":"Dorofeeva","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","article-title":"Current Developments and Challenges of mRNA Vaccines","volume":"24","author":"Chen","year":"2022","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.12.065_bib17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/all.16049","article-title":"Immunotherapeutic effects of specific and nonspecific mRNA-lipid nanoparticles in a mouse model of HDM-induced airway inflammation","volume":"79","author":"Thanasarnthungcharoen","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2023.04.008","article-title":"House dust mite allergy: The importance of house dust mite allergens for diagnosis and immunotherapy","volume":"158","author":"Huang","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaci.2004.11.024","article-title":"Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: major conformational IgE epitopes blocked by prodomains","volume":"115","author":"Takai","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib20","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1016\/j.vaccine.2006.04.064","article-title":"Intramuscular immunization with DNA construct containing Der p 2 and signal peptide sequences primed strong IgE production","volume":"24","author":"Tan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.12.065_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.074","article-title":"An mRNA vaccine encoding proteasome-targeted antigen enhances CD8(+) T cell immunity","volume":"381","author":"Ling","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.12.065_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.065_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.adn4955","article-title":"A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection","volume":"386","author":"Alameh","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.065_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.12.065_bib25","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/all.15230","article-title":"Immunoglobulin E response in health and disease beyond allergic disorders","volume":"77","author":"Colas","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/all.13382","article-title":"Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model","volume":"73","author":"Hesse","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.12.065_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1084\/jem.20041065","article-title":"Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization","volume":"201","author":"Traidl-Hoffmann","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.molmed.2011.05.014","article-title":"The role of innate immunity activation in house dust mite allergy","volume":"17","author":"Jacquet","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2362.2009.02109.x","article-title":"Molecular composition and biological activity of commercial birch pollen allergen extracts","volume":"39","author":"Focke","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.065_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001812","article-title":"Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery","volume":"10","author":"Ho","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2025.12.065_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/CMR.8.3.406","article-title":"Nucleic acid vaccines","volume":"8","author":"Vogel","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2025.12.065_bib33","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1080\/21645515.2017.1329070","article-title":"Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study","volume":"13","author":"Su","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2025.12.065_bib34","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa052916","article-title":"Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis","volume":"355","author":"Creticos","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2222.2008.03191.x","article-title":"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I\/IIa clinical trial","volume":"39","author":"Senti","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/pai.12964","article-title":"DNA and mRNA vaccination against allergies","volume":"29","author":"Scheiblhofer","year":"2018","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2107058","article-title":"Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines","volume":"385","author":"Thompson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib38","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00018-004-4255-0","article-title":"Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines","volume":"61","author":"Carralot","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.12.065_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.06.036","article-title":"Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens","volume":"124","author":"Roesler","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejcb.2018.06.003","article-title":"A comprehensive review of signal peptides: Structure, roles, and applications","volume":"97","author":"Owji","year":"2018","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11033-012-2108-8","article-title":"Structural biology of mite allergens","volume":"40","author":"Cui","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymthe.2025.12.065_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ymthe.2025.12.065_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.12.065_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.iac.2021.09.012","article-title":"Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy","volume":"42","author":"Dhamija","year":"2022","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.ymthe.2025.12.065_bib45","first-page":"52","article-title":"Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods","volume":"36","author":"Ragusa","year":"2004","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/cea.13169","article-title":"Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma","volume":"48","author":"Hesse","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib47","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/all.14908","article-title":"The role of allergen-specific IgE, IgG and IgA in allergic disease","volume":"76","author":"Shamji","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib48","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaci.2020.03.015","article-title":"IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy","volume":"146","author":"Sanchez Acosta","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib50","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2023.01.005","article-title":"The role of IgG(1) and IgG(4) as dominant IgE-blocking antibodies shifts during allergen immunotherapy","volume":"151","author":"Strobl","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib51","first-page":"139","article-title":"The role of Treg cell subsets in allergic disease","volume":"38","author":"Boonpiyathad","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/all.13553","article-title":"Persistent regulatory T-cell response 2 years after 3 years of grass tablet SLIT: Links to reduced eosinophil counts, sIgE levels, and clinical benefit","volume":"74","author":"Varona","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.065_bib54","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"A Spleen-Targeted Tolerogenic mRNA-LNPs Vaccine for the Treatment of Experimental Asthma","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.12.065_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.981126","article-title":"Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy","volume":"3","author":"Matsuda","year":"2022","journal-title":"Front. Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00011-021-01460-3","article-title":"Sublingual immunotherapy for 4 years increased the number of Foxp3(+) Treg cells, which correlated with clinical effects","volume":"70","author":"Terada","year":"2021","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ymthe.2025.12.065_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/imm.12789","article-title":"PI3K-Akt pathway enhances the differentiation of interleukin-27-induced type 1 regulatory T cells","volume":"152","author":"Nadya","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2025.12.065_bib58","first-page":"75","article-title":"Th1\/Th2 Immune Balance and Other T Helper Subsets in IgG4-Related Disease","volume":"401","author":"Moriyama","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.599083","article-title":"Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy","volume":"11","author":"Kirtland","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.065_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-022-02240-4","article-title":"Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production","volume":"20","author":"Muller","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2163785","article-title":"RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies","volume":"12","author":"Bigenwald","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2025.12.065_bib63","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.20082118","article-title":"Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells","volume":"206","author":"Gabrysova","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194080","article-title":"Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice","volume":"135","author":"Rochman","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.065_bib65","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mucimm.2024.03.012","article-title":"Sublingual allergen immunotherapy prevents house dust mite inhalant type 2 immunity through dendritic cell-mediated induction of Foxp3(+) regulatory T cells","volume":"17","author":"Van der Borght","year":"2024","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.109984","article-title":"Allergen specific immunotherapy regulates macrophage property in the airways","volume":"755","author":"Liu","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymthe.2025.12.065_bib67","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/all.16423","article-title":"Allergen-Specific Immunotherapy and Trained Immunity","volume":"80","author":"Martin-Cruz","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.ymthe.2025.12.065_bib68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2022.08.035","article-title":"Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans","volume":"78","author":"Lim","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/ACI.0000000000000706","article-title":"Novel vaccines for allergen-specific immunotherapy","volume":"21","author":"Akinfenwa","year":"2021","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib70","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1038\/s41596-025-01174-4","article-title":"The design, manufacture and LNP formulation of mRNA for research use","volume":"20","author":"Leighton","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2025.12.065_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice","volume":"15","author":"Ramos da Silva","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.065_bib72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-0716-1001-5_20","article-title":"Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma","volume":"2223","author":"Hesse","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.065_bib73","article-title":"Interleukin-10-alveolar macrophage cell membrane-coated nanoparticles alleviate airway inflammation and regulate Th17\/regulatory T cell balance in a mouse model","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625011414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625011414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:34:16Z","timestamp":1775057656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625011414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525001625011414"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.065","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergen-specific immunotherapy with Der p 1\/2 mRNA vaccines relieves house-dust-mite-induced allergic airway inflammation in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}